Background: Meningeal carcinomatosis (MC) is a rare complication in breast cancer (BC) with no efficient modality of treatment yet found; overall survival (OS) generally did not exceed six months. We reviewed the experience of the University of Florence focusing on prognostic factors and MC survival. Patients and methods: We analyzed 33 patients treated for MC from BC between 2002 and 2010. Results: Mean OS from MC diagnosis was 4.9 months. At survival analysis clinical stage emerged as the only statistical significant parameter (P50.009) among BC diagnosis features. Among MC diagnosis parameters, more than three metastases at diagnosis (P50.037), multimodality treatment (P50.014) and poor performance status (P50.003) reached the statistical significance. At multivariate analysis only performance status at MC diagnosis maintained the statistical significance (P50.0047; HR: 3.34; CI 95% 1.45–7.73). Conclusions: Our experience confirms that performance status is probably the most important prognostic factor in these patients. Multimodality approach is probably the best option.
Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: a single center experience / Icro Meattini;Lorenzo Livi;Calogero Saieva;Davide Franceschini;Livia Marrazzo;Daniela Greto;Vieri Scotti;Silvia Scoccianti;Fabiola Paiar;Lorenzo Bordi;Jacopo Nori;Luis Sanchez;Lorenzo Orzalesi;Simonetta Bianchi;Giampaolo Biti. - In: JOURNAL OF CHEMOTHERAPY. - ISSN 1120-009X. - ELETTRONICO. - 24:(2012), pp. 279-284. [10.1179/1973947812Y.0000000034]
Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: a single center experience
MEATTINI, ICRO;LIVI, LORENZO;MARRAZZO, LIVIA;SCOCCIANTI, SILVIA;PAIAR, FABIOLA;ORZALESI, LORENZO;Simonetta Bianchi;BITI, GIAMPAOLO
2012
Abstract
Background: Meningeal carcinomatosis (MC) is a rare complication in breast cancer (BC) with no efficient modality of treatment yet found; overall survival (OS) generally did not exceed six months. We reviewed the experience of the University of Florence focusing on prognostic factors and MC survival. Patients and methods: We analyzed 33 patients treated for MC from BC between 2002 and 2010. Results: Mean OS from MC diagnosis was 4.9 months. At survival analysis clinical stage emerged as the only statistical significant parameter (P50.009) among BC diagnosis features. Among MC diagnosis parameters, more than three metastases at diagnosis (P50.037), multimodality treatment (P50.014) and poor performance status (P50.003) reached the statistical significance. At multivariate analysis only performance status at MC diagnosis maintained the statistical significance (P50.0047; HR: 3.34; CI 95% 1.45–7.73). Conclusions: Our experience confirms that performance status is probably the most important prognostic factor in these patients. Multimodality approach is probably the best option.File | Dimensione | Formato | |
---|---|---|---|
Meattini et al 2013 J Chem - meningeal carcinomatosis.pdf
Accesso chiuso
Descrizione: Paper
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
100.08 kB
Formato
Adobe PDF
|
100.08 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.